JPML Won't Separate La. Avandia Suit From MDL
A federal judicial panel on Friday rejected Louisiana's bid to keep its suit alleging GlaxoSmithKline PLC failed to warn consumers of the risks associated with its diabetes medication Avandia separate from...To view the full article, register now.
Already a subscriber? Click here to view full article